Announcement on behalf of the subsidiary We Can Medicines Co. the lifting of non-competition directors approved by 2022 Annual General shareholder's Metting

 Announcement on behalf of the subsidiary We Can
Medicines Co. the lifting of non-competition directors
approved by 2022 Annual General shareholder's Metting

1.Date of the shareholders' meeting resolution:2022/05/27
2.Name and title of the managerial officer with permission
 to engage in competitive conduct:
Director:William Cheng
Director:Tsuey-Wen
Director:Mr.JP Liu
Director:Cherry Chang
Director:Ms.Wendland
3.Items of competitive conduct in which the officer is
permitted to engage:Since the main business items are the same as those
of the company.
4.Period of permission to engage in the competitive conduct:
Term of office as director of the company.
5.Circumstances of the resolution (please describe the
results of voting in accordance with Article 209 of the
Company Act):All shareholders present passed the proposal.
6.If the permitted competitive conduct belongs to the
operator of a mainland China enterprise, the name and
title of the directors (if it is not the operator of
a mainland China enterprise, please enter "N/A" below):N/A
7.Company name of the mainland China enterprise and the
officer's position in the enterprise:N/A
8.Address of the mainland China enterprise:N/A
9.Operations of the mainland China enterprise:N/A
10.Impact on the company's finance and business:N/A
11.If the directors have invested in the mainland China
enterprise, the monetary amount of the investment and
their shareholding ratio:N/A
12.Any other matters that need to be specified:NA